“Pathological complete response after neoadjuvant cyclin-dependent kinase 4/6 inhibitor and neoadjuvant endocrine therapy in locally advanced hormone receptor-positive breast cancer” (2024) Indian Journal of Case Reports, 10(10), pp. 322–324. doi:10.32677/ijcr.v10i10.4727.